Bibliography: Schizophrenia: Advances in Understanding and Treatment
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
2016
Bechtold J, Hipwell A, Lewis DA, et al: Concurrent and sustained cumulative effects of adolescent marijuana use on subclinical psychotic symptoms. Am J Psychiatry (Epub ahead of print, May 3, 2016)
Clementz BA, Sweeney JA, Hamm JP, et al: Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 2016; 173:373–384
Cristóbal-Narváez P, Sheinbaum T, Ballespí S, et al: Impact of adverse childhood experiences on psychotic-like symptoms and stress reactivity in daily life in nonclinical young adults. PLoS One 2016; 11:e0153557
Heilbronner U, Samara M, Leucht S, et al: The longitudinal course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects. Harv Rev Psychiatry 2016; 24:118–128
Kane JM, Robinson DG, Schooler NR, et al: Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry 2016; 173:362–372
McEvoy J, Citrome L: Brexpiprazole for the treatment of schizophrenia: a review of this novel serotonin-dopamine activity modulator. Clin Schizophr Relat Psychoses 2016; 9:177–186
Tek C, Kucukgoncu S, Guloksuz S, et al: Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications. Early Interv Psychiatry 2016; 10:193–202
2015
Connery HS: Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry 2015; 23:63–75
Farrell MS, Werge T, Sklar P, et al: Evaluating historical candidate genes for schizophrenia. Mol Psychiatry 2015; 20:555–562
Green MF, Horan WP, Lee J: Social cognition in schizophrenia. Nat Rev Neurosci 2015; 16:620–631
Haring L, Koido K, Vasar V, et al: Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index. Schizophr Res 2015; 169:22–29
Kane JM, Zukin S, Wang Y, et al: Efficacy and safety of cariprazine in acute exacerbation of schizophrenia: results from an international, phase III clinical trial. J Clin Psychopharmacol 2015; 35:367–373
Laurens KR, Luo L, Matheson SL, et al: Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry 2015; 15:205
Lee J, Takeuchi H, Fervaha G, et al: Subtyping schizophrenia by treatment response: antipsychotic development and the central role of positive symptoms. Can J Psychiatry 2015; 60:515–522
Leucht S, Winter-van Rossum I, Heres S, et al: The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics. Schizophr Bull 2015; 41:549–558
McFarlane WR, Levin B, Travis L, et al: Clinical and functional outcomes after 2 years in the Early Detection and Intervention for the Prevention of Psychosis multisite effectiveness trial. Schizophr Bull 2015; 41:30–43
Mueser KT, Penn DL, Addington J, et al: The NAVIGATE program for first-episode psychosis: rationale, overview, and description of psychosocial components. Psychiatr Serv 2015; 66:680–690
Pearlson GD: Etiologic, phenomenologic, and endophenotypic overlap of schizophrenia and bipolar disorder. Annu Rev Clin Psychol 2015; 11:251–281
Siu CO, Harvey PD, Agid O, et al: Insight and subjective measures of quality of life in chronic schizophrenia. Schizophr Res Cogn 2015; 2:127–132
2014
Bentall RP, de Sousa P, Varese F, et al: From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms. Soc Psychiatry Psychiatr Epidemiol 2014; 49:1011–1022
Correll CU, Kane JM: Schizophrenia: mechanism of action of current and novel treatments. J Clin Psychiatry 2014; 75:347–348
Keshavan MS, Vinogradov S, Rumsey J, et al: Cognitive training in mental disorders: update and future directions. Am J Psychiatry 2014; 171:510–522
Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511:421–427
Stan AD, Tamminga CA: New options for the treatment of schizophrenia: a clinical review of the three most recent antipsychotic drugs. Focus 2014; 12:127–135
2013
Andreasen NC, Liu D, Ziebell S, et al: Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry 2013; 170:609–615
Driver DI, Gogtay N, Rapoport JL: Childhood onset schizophrenia and early onset schizophrenia spectrum disorders. Child Adolesc Psychiatr Clin N Am 2013; 22:539–555
Greenwood TA, Swerdlow NR, Gur RE, et al: Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2013; 170:521–532
Heckers S, Barch DM, Bustillo J, et al: Structure of the psychotic disorders classification in DSM-5. Schizophr Res 2013; 150:11–14
Kranzler HN, Cohen SD: Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management. Child Adolesc Psychiatr Clin N Am 2013; 22:727–744
Leucht S, Cipriani A, Spineli L, et al: Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013; 382:951–962 (Reprinted in Focus 2014; 12:192–204)
McClellan J, Stock S: Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 2013; 52:976–990. http://www.jaacap.com/article/S0890-8567(13)00112-3/pdf
Sikich L: Diagnosis and evaluation of hallucinations and other psychotic symptoms in children and adolescents. Child Adolesc Psychiatr Clin N Am 2013; 22:655–673
Further Reading
Bechdolf A, Wagner M, Ruhrmann S, et al: Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 2012; 200:22–29
Cerimele JM, Durango A: Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies. J Clin Psychiatry 2012; 73:e1039–e1047
Clemmensen L, Vernal DL, Steinhausen HC: A systematic review of the long-term outcome of early onset schizophrenia. BMC Psychiatry 2012; 12:150
Kingdon DG, Turkington D: Cognitive-Behavioral Therapy of Schizophrenia. New York, Guilford, 1994
Lencer R, Harris MSH, Weiden PJ, et al: When Psychopharmacology Is Not Enough: Using Cognitive Behavioral Therapy Techniques for Persons With Persistent Psychosis. Boston, Hogrefe, 2011
Stone JM: Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? Ther Adv Psychopharmacol 2011; 1:5–18
Information & Authors
Information
Published In
History
Published in print: Summer 2016
Published online: 13 July 2016
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
There are no citations for this item
View Options
View options
PDF/ePub
View PDF/ePubGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).